Long-term experience of hyperbaric oxygen therapy for refractory radio- or chemotherapy-induced haemorrhagic cystitis

por Degener, Stephan, Pohle, Alexander, Strelow, Hartmut, Mathers, Michael J, Zumbé, Jürgen, Roth, Stephan, Brandt, Alexander S
Publicado 2015

Patients with Localised Prostate Cancer (T1 - T2) Show Improved Overall Long-Term Survival Compared to the Normal Population

por Mathers, Michael J., Roth, Stephan, Klinkhammer-Schalke, Monika, Gerken, Michael, Hofstaedter, Ferdinand, Wilm, Stefan, Klotz, Theodor
Publicado 2011

Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial

por Ohlmann, Carsten-Henning, Jäschke, Michelle, Jaehnig, Peter, Krege, Susanne, Gschwend, Jürgen, Rexer, Heidrun, Junker, Kerstin, Zillmann, Roger, Rüssel, Christoph, Hellmis, Eva, Suttmann, Henrik, Janssen, Martin, Marin, Jan, Hübner, Andreas, Mathers, Michael, Gleißner, Jochen, Scheffler, Michael, Feyerabend, Susan, Telle, Jens, Klier, Jörg, Stöckle, Michael
Publicado 2023

LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial

por Ohlmann, Carsten-Henning, Jäschke, Michelle, Jaehnig, Peter, Krege, Susanne, Gschwend, Jürgen, Rexer, Heidrun, Junker, Kerstin, Zillmann, Roger, Rüssel, Christoph, Hellmis, Eva, Suttmann, Henrik, Janssen, Martin, Marin, Jan, Hübner, Andreas, Mathers, Michael, Gleißner, Jochen, Scheffler, Michael, Feyerabend, Susan, Telle, Jens, Klier, Jörg, Stöckle, Michael
Publicado 2022